Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zymeworks (ZYME) EBT Margin (2021 - 2025)

Zymeworks' EBT Margin history spans 5 years, with the latest figure at 1649.26% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 159193.0% to 1649.26% in Q4 2025 year-over-year; TTM through Dec 2025 was 100.52%, a 7871.0% increase, with the full-year FY2025 number at 75.26%, up 7756.0% from a year prior.
  • EBT Margin hit 1649.26% in Q4 2025 for Zymeworks, down from 73.06% in the prior quarter.
  • Over the last five years, EBT Margin for ZYME hit a ceiling of 98.6% in Q4 2022 and a floor of 3794.31% in Q1 2022.
  • Historically, EBT Margin has averaged 726.79% across 5 years, with a median of 392.53% in 2024.
  • Biggest five-year swings in EBT Margin: skyrocketed 372977bps in 2023 and later tumbled -159193bps in 2025.
  • Tracing ZYME's EBT Margin over 5 years: stood at 506.54% in 2021, then surged by 119bps to 98.6% in 2022, then plummeted by -215bps to 113.46% in 2023, then skyrocketed by 49bps to 57.33% in 2024, then plummeted by -2777bps to 1649.26% in 2025.
  • Business Quant data shows EBT Margin for ZYME at 1649.26% in Q4 2025, 73.06% in Q3 2025, and 4.37% in Q2 2025.